BOUT ETF
CapForce IBD Breakout Opportunities ETF
BOUT ETF Overview
BOUT ETF (CapForce IBD Breakout Opportunities ETF) is managed by Capital-FORCE ETF with $15.1M in net assets. BOUT expense ratio is 0.80%, holding 31 positions across sectors including Financials, Health Care, Materials. Inception date: 2018-09-12.
BOUT performance shows a YTD return of 21.51%. The 1-year return is 17.14% and the 5-year return is 5.25%. BOUT dividend yield stands at 0.28%, paid annually.
BOUT top holdings include Travere Therapeutics Inc (7.4%), Ethos Technologies Inc (6.9%), Hinge Health Inc (6.8%), Enliven Therapeutics Inc (6.7%), Dave Inc Common Stock Usd.0001 (6.7%). Go to all BOUT holdings, BOUT sectors, or BOUT dividends.
BOUT can be compared against other funds. Use BOUT overlap to find shared positions, or BOUT vs another fund for a side-by-side view. BOUT alternatives are available via the screener, along with tax-loss harvesting opportunities.